Literature DB >> 8391993

Targeted delivery of hygromycin B using reconstituted Sendai viral envelopes lacking hemagglutinin-neuraminidase.

S Bagai1, D P Sarkar.   

Abstract

Hygromycin B was encapsulated in reconstituted Sendai viral envelopes containing only the fusion (F) protein (F-virosomes). Incubation of loaded F-virosomes with cultured HepG2 cells resulted in fusion mediated delivery of hygromycin B to the cell cytoplasm, as was inferred from inhibition of DNA synthesis. Binding of the F-virosomes to HepG2 cells was mediated by the interaction of terminal beta-galactose residues of fusion protein with asialoglycoprotein receptor on HepG2 cells, subsequently leading to fusion between the two membranes. The cytotoxic effect of hygromycin B enclosed in F-virosomes was comparable with that of F,HN-virosomes containing both hemagglutinin-neuraminidase (HN) and F protein and F,HNred-virosomes containing HN whose disulfide bonds were irreversibly reduced (HNred). Hygromycin B loaded fusogenic liposomes were prepared by coreconstituting the viral envelope containing only fusion protein with exogenous lipids. These fusogenic liposomes were found to be more active than F-virosomes at the same fusion protein concentrations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391993     DOI: 10.1016/0014-5793(93)81787-z

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  A 45,000-M(r) glycoprotein in the Sendai virus envelope triggers virus-cell fusion.

Authors:  M Kumar; M Q Hassan; S K Tyagi; D P Sarkar
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

2.  Pseudovirions as vehicles for the delivery of siRNA.

Authors:  Paul E Lund; Ryan C Hunt; Michael M Gottesman; Chava Kimchi-Sarfaty
Journal:  Pharm Res       Date:  2009-12-09       Impact factor: 4.200

3.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.